Jonathan Nugent
Investor Relations
Replay available
bioAffinity Technologies, Inc. (BIAF) Q3 2022 Earnings Call
bioAffinity Technologies, Inc. (NASDAQ: BIAF) Q3 2022 earnings conference call, held 2022-11-14. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Maria Zanes
President and Chief Executive Officer
Michael Edwards
Chief Financial Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Bioaffinity Technologies, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.987 -- 00:00:06.931 Good afternoon and welcome to the BioAffinity Technologies Third Quarter 2022 00:00:06.931 -- 00:00:10.813 Business Update and Financial Results Conference Call. 00:00:10.813 -- 00:00:15.816 I will now turn the call over to Jonathan Nugent, Investor Relations for BioAffinity. 00:00:15.816 -- 00:00:19.517 Thank you. Please go ahead. 00:00:20.499 -- 00:00:25.022 Thank you, Operator. Good morning, everyone, and thank you for joining the call. 00:00:25.022 -- 00:00:29.244 With me today is BioAffinity's President and Chief Executive Officer, Maria Zanes, who 00:00:29.244 -- 00:00:33.860 will provide an update of the company's recent business activity, and Michael Edwards, 00:00:33.860 -- 00:00:37.282 the company's chief financial officer, who will provide more detail on the company's 00:00:37.282 -- 00:00:39.242 financial results. 00:00:39.242 -- 00:00:44.024 Earlier this morning, BioAffinity issued a press release detailing business activity 00:00:44.024 -- 00:00:45.565 for the third quarter ended September 30, 2022. 00:00:45.565 -- 00:00:47.565 BioAffinity 00:00:49.286 -- 00:00:52.528 encourages listeners to review the press release, which is available on the company's 00:00:52.528 -- 00:00:55.348 website at www.bioaffinitytech.com. 00:00:57.168 -- 00:01:01.329 This call is being recorded and replay will be available on the investor section of the 00:01:01.329 -- 00:01:04.830 BioAffinity website for approximately 45 days. 00:01:04.830 -- 00:01:08.391 This presentation contains forward-looking statements within the meaning of the Private 00:01:08.391 -- 00:01:11.752 Securities Litigation Reform Act of 1995, 00:01:11.752 -- 00:01:14.512 which are subject to risks and uncertainties. 00:01:14.512 -- 00:01:20.454 The company may, in some c...